Serena Marchiò

Research output

Research output per year 1998 2012 2013 2015 2016 2021

• 44 Article
• 2 Review article

Research output per year

Research output per year

Search results

• 2019

  A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies

  Quaglia, S., Ferrara, F., De Leo, L., Ziberna, F., Vatta, S., Marchiò, S., Sblattero, D., Ventura, A. & Not, T., Feb 15 2019, In: Journal of immunology (Baltimore, Md. : 1950). 202, 4, p. 1079-1087 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Glutens 100%
  • Celiac Disease 87%
  • Autoantibodies 73%
  • transglutaminase 2 63%
  • Serum 36%

• A functional idiotype/anti-idiotype network is active in genetically gluten-intolerant individuals negative for both celiac disease–related intestinal damage and serum autoantibodies

  Quaglia, S., Ferrara, F., De Leo, L., Ziberna, F., Vatta, S., Marchiò, S., Sblattero, D., Ventura, A. & Not, T., 2019, In: Journal of Immunology. 202, 4, p. 1079-1087 9 p.

  Research output: Contribution to journal › Article › peer-review

• Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review

  Chohan, M. O., Marchiò, S., Morrison, L. A., Sidman, R. L., Cavenee, W. K., Dejana, E., Yonas, H., Pasqualini, R. & Arap, W., Apr 1 2019, In: JAMA Neurology. 76, 4, p. 492-500 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Central Nervous System Cavernous Hemangioma 100%
  • Drug Repositioning 17%
  • Penetrance 14%
  • Loss of Function Mutation 14%
  • Germ-Line Mutation 14%
• 2018

  Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review

  Chohan, M. O., Marchiò, S., Morrison, L. A., Sidman, R. L., Cavenee, W. K., Dejana, E., Yonas, H., Pasqualini, R. & Arap, W., Jan 1 2018, (Accepted/In press) In: JAMA Neurology.

  Research output: Contribution to journal › Article › peer-review

  • Central Nervous System Cavernous Hemangioma 100%
  • Drug Repositioning 17%
  • Penetrance 14%
  • Loss of Function Mutation 14%
  • Germ-Line Mutation 14%

• Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: Preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates

  Staquicini, D. I., D'Angelo, S., Ferrara, F., Karjalainen, K., Sharma, G., Smith, T. L., Tarleton, C. A., Jaalouk, D. E., Kuniyasu, A., Baze, W. B., Chaffee, B. K., Hanley, P. W., Barnhart, K. F., Koivunen, E., Marchiò, S., Sidman, R. L., Cortes, J. E., Kantarjian, H. M., Arap, W. & Pasqualini, R., May 22 2018, In: Pharmacogenomics Journal. 18, 3, p. 436-443 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Peptidomimetics 100%
  • Primates 63%
  • Investigational New Drug Application 59%
  • Lymphoma 57%
  • Rodentia 56%
• 2017

  Autoantibodies against the cell surface-Associated chaperone GRP78 stimulate tumor growth via tissue factor

  Al-Hashimi, A. A., Lebeau, P., Majeed, F., Polena, E., Lhotak, Š., Collins, C. A. F., Pinthus, J. H., Gonzalez-Gronow, M., Hoogenes, J., Pizzo, S. V., Crowther, M., Kapoor, A., Rak, J., Gyulay, G., D'Angelo, S., Marchiò, S., Pasqualini, R., Arap, W., Shayegan, B. & Austin, R. C., Jan 1 2017, In: Journal of Biological Chemistry. 292, 51, p. 21180-21192 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Heparin Derivative 100%
  • Thromboplastin 67%
  • Autoantibodies 55%
  • Procoagulant 46%
  • Neutralization 30%

• BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation

  Lewis, V. O., Devarajan, E., Cardó-Vila, M., Thomas, D. G., Kleinerman, E. S., Marchiò, S., Sidman, R. L., Pasqualini, R. & Arap, W., Jul 25 2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 30, p. 8065-8070 6 p.

  Research output: Contribution to journal › Article › peer-review

  • bone metastasis-targeting peptidomimetic-11 100%
  • Interleukin-11 Receptors 49%
  • Osteosarcoma 43%
  • Pharmaceutical Preparations 17%
  • Lung 11%

• Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates.

  Staquicini, D. I., D'Angelo, S., Ferrara, F., Karjalainen, K., Sharma, G., Smith, T. L., Tarleton, C. A., Jaalouk, D. E., Kuniyasu, A., Baze, W. B., Chaffee, B. K., Hanley, P. W., Barnhart, K. F., Koivunen, E., Marchio, S., Sidman, R. L., Cortes, J. E., Kantarjian, H. M., Arap, W. & Pasqualini, R., Dec 1 2017, In: Pharmacogenomics Journal.

  Research output: Contribution to journal › Article › peer-review

• 2016

  BCAM and LAMA5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of KRAS-mutant colorectal cancer

  Bartolini, A., Cardaci, S., Lamba, S. E., Oddo, D., Marchiò, C., Cassoni, P., Amoreo, C. A., Corti, G., Testori, A., Bussolino, F., Pasqualini, R., Arap, W., Corà, D., Di Nicolantonio, F. & Marchiò, S., Oct 1 2016, In: Clinical Cancer Research. 22, 19, p. 4923-4933 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Endothelium 100%
  • Tumor Microenvironment 97%
  • Colorectal Neoplasms 89%
  • Neoplasm Metastasis 46%
  • Liver 38%

• BCAM and LAMA5 mediate the recognition between tumor cells and the endothelium in the metastatic spreading of KRAS-mutant colorectal cancer

  Bartolini, A., Cardaci, S., Lamba, S., Oddo, D., Marchiò, C., Cassoni, P., Amoreo, C. A., Corti, G., Testori, A., Bussolino, F., Pasqualini, R., Arap, W., Corà, D., Di Nicolantonio, F. & Marchiò, S., Oct 1 2016, In: Clinical Cancer Research. 22, 19, p. 4923-4933 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Endothelium 100%
  • Tumor Microenvironment 97%
  • Colorectal Neoplasms 89%
  • Neoplasm Metastasis 46%
  • Liver 38%

• Brain endothelial cell-targeted gene therapy of neurovascular disorders

  Marchiò, S., Sidman, R. L., Arap, W. & Pasqualini, R., Jun 1 2016, In: EMBO Molecular Medicine. 8, 6, p. 592-594 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Genetic Therapy 100%
  • Endothelial Cells 79%
  • Incontinentia Pigmenti 56%
  • Brain 52%
  • Molecular Medicine 51%

• Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity

  Cardó-Vila, M., Marchiò, S., Sato, M., Staquicini, F. I., Smith, T. L., Bronk, J. K., Yin, G., Zurita, A. J., Sun, M., Behrens, C., Sidman, R. L., Lee, J. J., Hong, W. K., Wistuba, I. I., Arap, W. & Pasqualini, R., Aug 1 2016, In: American Journal of Pathology. 186, 8, p. 2162-2170 9 p.

  Research output: Contribution to journal › Article › peer-review

  • bone metastasis-targeting peptidomimetic-11 100%
  • Interleukin-11 Receptors 74%
  • Lung Neoplasms 32%
  • Ligands 29%
  • Neoplasms 13%

• Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors

  Dondossola, E., Dobroff, A. S., Marchiò, S., Cardó-Vila, M., Hosoya, H., Libutti, S. K., Corti, A., Sidman, R. L., Arap, W. & Pasqualini, R., Feb 23 2016, In: Proceedings of the National Academy of Sciences of the United States of America. 113, 8, p. 2223-2228 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Necrosis Factor-alpha 100%
  • Neoplasms 45%
  • Circulating Neoplastic Cells 34%
  • Lewis Lung Carcinoma 19%
  • Experimental Melanomas 17%

• Self-targeting of TNF-releasing cancer cells in preclinical models of primary and metastatic tumors

  Dondossola, E., Dobroff, A. S., Marchiò, S., Cardó-Vila, M., Hosoya, H., Libutti, S. K., Corti, A., Sidman, R. L., Arap, W. & Pasqualini, R., Feb 23 2016, In: Proceedings of the National Academy of Sciences of the United States of America. 113, 8, p. 2223-2228 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Tumor Necrosis Factor-alpha 100%
  • Neoplasms 45%
  • Circulating Neoplastic Cells 34%
  • Lewis Lung Carcinoma 19%
  • Experimental Melanomas 17%

• Targeted molecular-genetic imaging and liganddirected therapy in aggressive variant prostate cancer

  Ferrara, F., Staquicini, D. I., Driessen, W. H. P., D'Angelo, S., Dobroff, A. S., Barry, M., Lomo, L. C., Staquicini, F. I., Cardó-Vila, M., Soghomonyan, S., Alauddin, M. M., Flores, L. G., Arap, M. A., Lauer, R. C., Mathew, P., Efstathiou, E., Aparicio, A. M., Troncoso, P., Navone, N. M., Logothetis, C. J., & 5 othersMarchiò, S., Gelovani, J. G., Sidman, R. L., Pasqualini, R. & Arap, W., Nov 8 2016, In: Proceedings of the National Academy of Sciences of the United States of America. 113, 45, p. 12786-12791 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Molecular Imaging 100%
  • Molecular Biology 68%
  • Prostatic Neoplasms 67%
  • Bacteriophages 35%
  • Theranostic Nanomedicine 32%

• Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes

  Dobroff, A. S., D'Angelo, S., Eckhardt, B. L., Ferrara, F., Staquicini, D. I., Cardó-Vila, M., Staquicini, F. I., Nunes, D. N., Kim, K., Driessen, W. H. P., Hajitou, A., Lomo, L. C., Barry, M., Krishnamurthy, S., Sahin, A., Woodward, W. A., Prossnitz, E. R., Anderson, R. L., Dias-Neto, E., Brown-Glaberman, U. A., & 9 othersRoyce, M. E., Ueno, N. T., Cristofanilli, M., Hortobagyi, G. N., Marchiò, S., Gelovani, J. G., Sidman, R. L., Arap, W. & Pasqualini, R., Nov 8 2016, In: Proceedings of the National Academy of Sciences of the United States of America. 113, 45, p. 12780-12785 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Inflammatory Breast Neoplasms 100%
  • Theranostic Nanomedicine 89%
  • Transcriptome 62%
  • Bacteriophages 53%
  • Dependovirus 50%
• 2015

  Ligand-targeted theranostic nanomedicines against cancer

  Yao, V. J., D'Angelo, S., Butler, K. S., Theron, C., Smith, T. L., Marchiò, S., Gelovani, J. G., Sidman, R. L., Dobroff, A. S., Brinker, C. J., Bradbury, A. R. M., Arap, W. & Pasqualini, R., Oct 27 2015, (Accepted/In press) In: Journal of Controlled Release.

  Research output: Contribution to journal › Article › peer-review

  • Theranostic Nanomedicine 100%
  • Nanocarrier 81%
  • Ligands 53%
  • Peptide 32%
  • Neoplasms 24%

• Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion

  Cossu, I., Bottoni, G., Loi, M., Emionite, L., Bartolini, A., Di Paolo, D., Brignole, C., Piaggio, F., Perri, P., Sacchi, A., Curnis, F., Gagliani, M. C., Bruno, S., Marini, C., Gori, A., Longhi, R., Murgia, D., Sementa, A. R., Cilli, M., Tacchetti, C., & 5 othersCorti, A., Sambuceti, G., Marchiò, S., Ponzoni, M. & Pastorino, F., Nov 1 2015, In: Biomaterials. 68, p. 89-99 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Drug delivery 100%
  • Nanocarrier 80%
  • Tumors 76%
  • Neuroblastoma 74%
  • Peptides 48%

• PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3

  Salameh, A., Lee, A. K., Cardó-Vila, M., Nunes, D. N., Efstathiou, E., Staquicini, F. I., Dobroff, A. S., Marchiò, S., Navone, N. M., Hosoya, H., Lauer, R. C., Wen, S., Salmeron, C. C., Hoang, A., Newsham, I., Lima, L. A., Carraro, D. M., Oliviero, S., Kolonin, M. G., Sidman, R. L., & 9 othersDo, K. A., Troncoso, P., Logothetis, C. J., Brentani, R. R., Calin, G. A., Cavenee, W. K., Dias-Neto, E., Pasqualini, R. & Arap, W., Jul 7 2015, In: Proceedings of the National Academy of Sciences of the United States of America. 112, 27, p. 8403-8408 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Long Noncoding RNA 100%
  • Prostatic Neoplasms 73%
  • Antigens 58%
  • RNA Editing 21%
  • Inosine 10%

• Synchronous down-modulation of miR-17 family members is an early causative event in the retinal angiogenic switch

  Nunes, D. N., Dias-Neto, E., Cardó-Vila, M., Edwards, J. K., Dobroff, A. S., Giordano, R. J., Mandelin, J., Brentani, H. P., Hasselgren, C., Yao, V. J., Marchiò, S., Pereira, C. A. B., Passetti, F., Calin, G. A., Sidman, R. L., Arap, W. & Pasqualini, R., Mar 24 2015, In: Proceedings of the National Academy of Sciences of the United States of America. 112, 12, p. 3770-3775 6 p.

  Research output: Contribution to journal › Article › peer-review

  • MicroRNAs 100%
  • Retinal Neovascularization 41%
  • Biological Models 39%
  • Hypoxia-Inducible Factor 1 37%
  • Retinopathy of Prematurity 37%

• The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

  Pignochino, Y., Dell'Aglio, C., Inghilleri, S., Zorzetto, M., Basiricò, M., Capozzi, F., Canta, M., Piloni, D., Cemmi, F., Sangiolo, D., Gammaitoni, L., Soster, M., Marchiò, S., Pozzi, E., Morbini, P., Luisetti, M., Aglietta, M., Grignani, G. & Stella, G. M., May 8 2015, In: BMC Cancer. 15, 1, 374.

  Research output: Contribution to journal › Article › peer-review

  • Everolimus 100%
  • Sorafenib 97%
  • Malignant Mesothelioma 96%
  • radixin 48%
  • moesin 46%

• The neuronal pentraxin-2 pathway is an unrecognized target in human neuroblastoma, which also offers prognostic value in patients

  Bartolini, A., Di Paolo, D., Noghero, A., Murgia, D., Sementa, A. R., Cilli, M., Pasqualini, R., Arap, W., Bussolino, F., Ponzoni, M., Pastorino, F. & Marchiò, S., Oct 15 2015, In: Cancer Research. 75, 20, p. 4265-4271 7 p.

  Research output: Contribution to journal › Article › peer-review

  • neuronal pentraxin 100%
  • Neuroblastoma 52%
  • Peptides 16%
  • Ligands 12%
  • Vascular Tissue Neoplasms 12%
• 2014

  Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer

  Parri, M., Pietrovito, L., Grandi, A., Campagnoli, S., De Camilli, E., Bianchini, F., Marchiò, S., Bussolino, F., Jin, B., Sarmientos, P., Grandi, G., Viale, G., Pileri, P., Chiarugi, P. & Grifantini, R., Oct 1 2014, In: Angiogenesis. 17, 4, p. 881-896 16 p.

  Research output: Contribution to journal › Article › peer-review

  • Angiopoietins 100%
  • Angiopoietin-like Proteins 77%
  • Capillary Crystal 30%
  • Protein 28%
  • Endothelial Progenitor Cells 28%

• Anti-cancer effect and gene modulation of ET-743 in human biliary tract carcinoma preclinical models

  Peraldo-Neia, C., Cavalloni, G., Soster, M., Gammaitoni, L., Marchiò, S., Sassi, F., Trusolino, L., Bertotti, A., Medico, E., Capussotti, L., Aglietta, M. & Leone, F., Dec 5 2014, In: BMC Cancer. 14, 1, 918.

  Research output: Contribution to journal › Article › peer-review

  • Trabectedin 100%
  • Biliary Tract 69%
  • Neoplasm Genes 67%
  • Carcinoma 41%
  • Drug Therapy 18%
• 2013

  A peptide from the extracellular region of the synaptic protein α Neurexin stimulates angiogenesis and the vascular specific tyrosine kinase Tie2

  Graziano, S., Marchiò, S., Bussolino, F. & Arese, M., Mar 22 2013, In: Biochemical and Biophysical Research Communications. 432, 4, p. 574-579 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Tyrosine 100%
  • Protein-Tyrosine Kinases 99%
  • Angiogenic 80%
  • Peptides 69%
  • Blood Vessels 64%

• Emerging lymphae for the fountain of life

  Marchiò, S., Astanina, E. & Bussolino, F., Mar 6 2013, In: EMBO Journal. 32, 5, p. 609-611 3 p.

  Research output: Contribution to journal › Article › peer-review

• Luminescent silica nanoparticles for cancer diagnosis

  Arap, W., Pasqualini, R., Montalti, M., Petrizza, L., Prodi, L., Rampazzo, E., Zaccheroni, N. & Marchió, S., Jun 2013, In: Current Medicinal Chemistry. 20, 17, p. 2195-2211 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Silicon Dioxide 100%
  • Nanoparticles 78%
  • Luminiscence Type 62%
  • Theranostic Nanomedicine 46%
  • Nanoparticle 43%

• Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings

  Loi, M., Di Paolo, D., Soster, M., Brignole, C., Bartolini, A., Emionite, L., Sun, J., Becherini, P., Curnis, F., Petretto, A., Sani, M., Gori, A., Milanese, M., Gambini, C., Longhi, R., Cilli, M., Allen, T. M., Bussolino, F., Arap, W., Pasqualini, R., & 4 othersCorti, A., Ponzoni, M., Marchiò, S. & Pastorino, F., 2013, In: Journal of Controlled Release. 170, 2, p. 233-241 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Nanocarrier 100%
  • Neuroblastoma 92%
  • Bacteriophages 91%
  • Peptides 59%
  • Peptide 53%

• The combination of sorafenib and everolimus abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models

  Pignochino, Y., Dell'Aglio, C., Basiricò, M., Capozzi, F., Soster, M., Marchiò, S., Bruno, S., Gammaitoni, L., Sangiolo, D., Torchiaro, E., D'Ambrosio, L., Fagioli, F., Ferrari, S., Alberghini, M., Picci, P., Aglietta, M. & Grignani, G., Apr 15 2013, In: Clinical Cancer Research. 19, 8, p. 2117-2131 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Everolimus 100%
  • Sorafenib 97%
  • Osteosarcoma 82%
  • Up-Regulation 57%
  • Methylnitronitrosoguanidine 36%

• The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry

  Cardaci, S., Soster, M., Bussolino, F. & Marchiò, S., Sep 17 2013, In: FEBS Letters. 587, 18, p. 2943-2951 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Virus Internalization 100%
  • Glycoprotein 74%
  • HIV-1 70%
  • Glycoproteins 68%
  • Virus Attachment 21%
• 2012

  A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6

  Marchiò, S., Soster, M., Cardaci, S., Muratore, A., Bartolini, A., Barone, V., Ribero, D., Monti, M., Bovino, P., Sun, J., Giavazzi, R., Asioli, S., Cassoni, P., Capussotti, L., Pucci, P., Bugatti, A., Rusnati, M., Pasqualini, R., Arap, W. & Bussolino, F., Nov 2012, In: EMBO Molecular Medicine. 4, 11, p. 1156-1175 20 p.

  Research output: Contribution to journal › Article › peer-review

  • Angiopoietins 100%
  • Cadherins 70%
  • Integrins 65%
  • Hepatocytes 58%
  • Colorectal Neoplasms 55%

• Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas

  Cavalloni, G., Peraldo-Neia, C., Sarotto, I., Gammaitoni, L., Migliardi, G., Soster, M., Marchiò, S., Aglietta, M. & Leone, F., Jul 2012, In: Molecular Cancer Therapeutics. 11, 7, p. 1528-1538 11 p.

  Research output: Contribution to journal › Article › peer-review

  • saracatinib 100%
  • Biliary Tract 61%
  • Carcinoma 36%
  • src-Family Kinases 14%
  • Heterografts 11%

• IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21Cip1/Waf1-mediated mechanism

  Napione, L., Strasly, M., Meda, C., Mitola, S., Alvaro, M., Doronzo, G., Marchiò, S., Giraudo, E., Primo, L., Arese, M. & Bussolino, F., 2012, In: Angiogenesis. 15, 4, p. 713-725 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Cell Cycle Resting Phase 100%
  • G1 Phase 86%
  • Interleukin-12 84%
  • Innate Immunity 76%
  • Endothelial Cells 61%

• SERS active Ag nanoparticles in mesoporous silicon: Detection of organic molecules and peptide-antibody assays

  Virga, A., Rivolo, P., Descrovi, E., Chiolerio, A., Digregorio, G., Frascella, F., Soster, M., Bussolino, F., Marchiò, S., Geobaldo, F. & Giorgis, F., Jun 2012, In: Journal of Raman Spectroscopy. 43, 6, p. 730-736 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Raman scattering 100%
  • Silver nanoparticles 99%
  • Peptides 90%
  • Antibodies 87%
  • Assays 80%

• Targeted dual-color silica nanoparticles provide univocal identification of micrometastases in preclinical models of colorectal cancer

  Soster, M., Juris, R., Bonacchi, S., Genovese, D., Montalti, M., Rampazzo, E., Zaccheroni, N., Garagnani, P., Bussolino, F., Prodi, L. & Marchiò, S., 2012, In: International Journal of Nanomedicine. 7, p. 4797-4807 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Silica nanoparticles 100%
  • Polyethylene glycols 85%
  • Neoplasm Micrometastasis 84%
  • Ethylene Glycol 81%
  • Silicon Dioxide 75%
• 2010

  Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

  Loi, M., Marchiò, S., Becherini, P., Di Paolo, D., Soster, M., Curnis, F., Brignole, C., Pagnan, G., Perri, P., Caffa, I., Longhi, R., Nico, B., Bussolino, F., Gambini, C., Ribatti, D., Cilli, M., Arap, W., Pasqualini, R., Allen, T. M., Corti, A., & 2 othersPonzoni, M. & Pastorino, F., Jul 2010, In: Journal of Controlled Release. 145, 1, p. 66-73 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Glutamyl Aminopeptidase 100%
  • Doxorubicin 90%
  • Neuroblastoma 87%
  • Endothelial Cells 64%
  • CD13 Antigens 62%
• 2009

  Targeting the extracellular signature of metastatic colorectal cancers

  Marchi, S., Arap, W. & Pasqualini, R., Mar 2009, In: Expert Opinion on Therapeutic Targets. 13, 3, p. 363-379 17 p.

  Research output: Contribution to journal › Article › peer-review

  • Spreading 100%
  • Colorectal Neoplasms 75%
  • Neoplasm Metastasis 58%
  • Drug 49%
  • Liver 36%
• 2007

  A new computational approach to analyze human protein complexes and predict novel protein interactions

  Zanivan, S., Cascone, I., Peyron, C., Molineris, I., Marchio, S., Caselle, M. & Bussolino, F., Dec 4 2007, In: Genome Biology. 8, 12, R256.

  Research output: Contribution to journal › Article › peer-review

  • early endosome antigen 1 100%
  • gene expression 85%
  • protein 79%
  • p21-Activated Kinases 79%
  • endosomes 68%
• 2005

  Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein

  Marchiò, S., Alfano, M., Primo, L., Gramaglia, D., Butini, L., Gennero, L., De Vivo, E., Arap, W., Giacca, M., Pasqualini, R. & Bussolino, F., Apr 1 2005, In: Blood. 105, 7, p. 2802-2811 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Viral Envelope Proteins 100%
  • Spreading 75%
  • Glycoprotein 65%
  • HIV-1 62%
  • Glycoproteins 61%

• Identification of CD36 molecular features required for its in vitro angiostatic activity

  Primo, L., Ferrandi, C., Roca, C., Marchio, S., Di Blasio, L., Alessio, M. & Bussolino, F., Oct 2005, In: FASEB Journal. 19, 12, p. 1713-1715 3 p.

  Research output: Contribution to journal › Article › peer-review
• 2004

  Aminopeptidase A is a functional target in angiogenic blood vessels

  Marchiò, S., Lahdenranta, J., Schlingemann, R. O., Valdembri, D., Wesseling, P., Arap, M. A., Hajitou, A., Ozawa, M. G., Trepel, M., Giordano, R. J., Nanus, D. M., Dijkman, H. B. P. M., Oosterwijk, E., Sidman, R. L., Cooper, M. D., Bussolino, F., Pasqualini, R. & Arap, W., Feb 2004, In: Cancer Cell. 5, 2, p. 151-162 12 p.

  Research output: Contribution to journal › Article › peer-review

  • Glutamyl Aminopeptidase 100%
  • Blood Vessels 35%
  • Vascular Tissue Neoplasms 24%
  • Peptide Library 11%
  • Peptides 11%
• 1999

  c-fos-Induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro

  Marconcini, L., Marchio, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F. & Oliviero, S., Aug 17 1999, In: Proceedings of the National Academy of Sciences of the United States of America. 96, 17, p. 9671-9676 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Vascular Endothelial Growth Factor D 100%
  • In Vitro Techniques 28%
  • Umbilical Cord 14%
  • Human Umbilical Vein Endothelial Cells 14%
  • Vascular Endothelial Growth Factor Receptor-3 12%

• Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells

  Marchiò, S., Primo, L., Pagano, M., Palestro, G., Albini, A., Veikkola, T., Cascone, I., Alitalo, K. & Bussolino, F., Sep 24 1999, In: Journal of Biological Chemistry. 274, 39, p. 27617-27622 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Vascular Endothelial Growth Factor C 100%
  • Proliferative 97%
  • Kaposi's Sarcoma 86%
  • Angiogenic 53%
  • Growth Factor 43%
• 1998

  Overexpression of the RON gene in human breast carcinoma

  Maggiora, P., Marchio', S., Stella, M. C., Giai, M., Belfiore, A., De Bortoli, M., Di Renzo, M. F., Costantino, A., Sismondi, P. & Comoglio, P. M., Jun 4 1998, In: Oncogene. 16, 22, p. 2927-2933 7 p.

  Research output: Contribution to journal › Article › peer-review

  • rice bran saccharide 100%
  • Breast Neoplasms 37%
  • RON protein 34%
  • macrophage stimulating protein 33%
  • Genes 23%